II Workshop sobre Transferencia del Conocimiento Científico en la Distrofia Muscular de Duchenne
La Compañía SOM Biotech estuvo presente en el II Workshop sobre Transferencia del Conocimiento Científico en la […]
Continue ReadingSOM Biotech licenses its first product and expands to the United States
The med-tech biopharmaceutical company SOM Biotech, specializing in repurposing drugs to treat rare nervous system […]
Continue ReadingSOM Biotech at the 2017 New York Venture Summit
SOM Biotech was selected to present at the 2017 New York Venture Summit in front […]
Continue Reading21st Summer School of the University of Barcelona
Dr. Raúl Insa, SOM Biotech CEO, was invited to the 21st Summer School of the University […]
Continue Reading9th Summer School on Medicines
Dr. Raúl Insa, SOM Biotech CEO, was the invited speaker at Closing Session of 9th […]
Continue ReadingSOM Biotech closed €2M funding round and opens €10M Series A
SOM Biotech closed €2M funding round on January 2017 where 18 international investors from 10 […]
Continue ReadingSOM Biotech at World Orphan Drug Congress USA 2017
SOM Biotech attended the World Orphan Drug Congress USA 2017 (WODC) hold in Washington, USA […]
Continue ReadingSOM Biotech at BIO Convention 2017
SOM Biotech attended last BIO Convention on June 19th-22nd 2017 in San Diego, CA. Michael […]
Continue ReadingSOM Biotech stands for Responsible Innovation
SOM Biotech is one of the European companies participating in the EU Compass program, Biomedicine field. […]
Continue Reading